Search

everythinglearnresearchcommunity

for

Search:↓

VYC-15L is a safe and effective lip filler that lasts up to a year.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Plant-based ingredients are effective and safe for modern skincare products.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil effectively treats female pattern hair loss.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Bridging anticoagulation may raise post-surgery bleeding risks.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Low-level laser therapy effectively treats female hair loss, increasing hair count by 51%.

AGA linked to worse COVID-19 outcomes in men.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.